Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Hashim, Hayder
ATRIUM, NCT05335928: Abatacept in Immune Checkpoint Inhibitor Myocarditis	Recruiting	3	390	Canada, US	Abatacept plus, Orencia, Placebo	Massachusetts General Hospital, Bristol-Myers Squibb	Myocarditis Acute, Cancer	11/26	04/27
COSIRA-II, NCT05102019: Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II	Recruiting	N/A	380	Canada, US	Arm 1: treatment with Neovasc Reducer, Arm 2 (control): Implantation procedure with no device implanted, Arm 3 (unblinded, non-randomized): Single arm registry	Neovasc Inc., Shockwave Medical, Inc.	Refractory Angina	06/24	12/28
PROTECT IV, NCT04763200: Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function	Recruiting	N/A	1252	Europe, Canada, US	Impella CP® / Impella CP® with SmartAssist® / Impella 2.5®, IABP Intra-aortic balloon pump	Abiomed Inc.	Left Ventricular Dysfunction, Coronary Artery Disease	03/26	10/27